Priya Sachdeva

Stock Analyst at UBS

(0.22)

# 4,365

Out of 5,044 analysts

5

Total ratings

20%

Success rate

-11.36%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$330 → $335	$235.50	+42.25%	4	Jul 30, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$10.62	+60.08%	1	Jan 21, 2025

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $235.50

Upside: +42.25%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $10.62

Upside: +60.08%